[1] KURTZ SM, ONG KL, LAU E, et al. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. JBJS. 2014;96(8):624-630.
[2] KURTZ S, ONG K, LAU E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. JBJS. 2007;89(4):780-785.
[3] GIBON E, COURPIED JP, HAMADOUCHE M. Total joint replacement and blood loss: what is the best equation? Int Orthop. 2013;37(4): 735-739.
[4] HALLSTROM B, SINGAL B, COWEN ME, et al. The Michigan experience with safety and effectiveness of tranexamic acid use in hip and knee arthroplasty. JBJS. 2016;98(19):1646-1655.
[5] KIM JL, PARK JH, HAN S, et al. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty. 2017;32(1): 320-325.
[6] LEVINE BR, HAUGHOM B, STRONG B, et al. Blood management strategies for total knee arthroplasty. J Am Acad Orthop Surg. 2014; 22(6): 361-371.
[7] BIERBAUM BE, CALLAGHAN JJ, GALANTE JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. JBJS. 1999; 81(1): 2-10.
[8] KALAIRAJAH Y, SIMPSON D, COSSEY AJ, et al. Blood loss after total knee replacement: effects of computer-assisted surgery. JBJS. 2005; 87(11):1480-1482.
[9] HARRIS RN, MOSKAL JT, CAPPS SG. Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. J Arthroplasty. 2015;30(2): 192-195.
[10] BENONI G, LETHAGEN S, FREDIN H. The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. Thromb Res. 1997;85(3): 195-206.
[11] FILLINGHAM YA, KAYUPOV E, PLUMMER DR, et al. The James A. Rand Young Investigator's Award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplasty. 2016;31(9):26-30.
[12] LIN ZX, WOOLF SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics. 2016; 39(2): 119-130.
[13] CAO G, HUANG Z, XIE J, et al. The effect of oral versus intravenous tranexamic acid in reducing blood loss after primary total hip arthroplasty: a randomized clinical trial. Thromb Res. 2018;164: 48-53.
[14] WU Y, ZENG Y, HU Q, et al. Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. Thromb Res. 2018;171:143-148.
[15] WANG D, WANG HY, CAO C, et al. Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration. Sci Rep. 2018; 8(1):13579.
[16] ZHAO HY, XIANG MY, XIA YY, et al. Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial. Int Orthop. 2018; 42(11):2535-2542.
[17] CAO G, XIE J, HUANG Z, et al. Efficacy and safety of multiple boluses of oral versus intravenous tranexamic acid at reducing blood loss after primary total knee arthroplasty without a tourniquet: A prospective randomized clinical trial. Thromb Res. 2018;171: 68-73.
[18] KAYUPOV E, FILLINGHAM YA, OKROJ K, et al. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial. JBJS. 2017;99(5): 373-378.
[19] YUAN X, LI B, WANG Q, et al. Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: a prospective, randomized, controlled study. J Arthroplasty. 2017;32(9): 2738-2743.
[20] LUO ZY, WANG HY, WANG D, et al. Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study. J Arthroplasty. 2018;33(3):786-793.
[21] PANTELI M, PAPAKOSTIDIS C, DAHABREH Z, et al. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee. 2013;20(5):300-309.
[22] RONDAY HK, TE KOPPELE JM, GREENWALD RA, et al. Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis. Br J Rheumatol.1998;37(1):34-38.
[23] KONIG G, HAMLIN BR, WATERS JH. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty. 2013;28(9): 1473-1476.
[24] FU DJ, CHENG C, LIN G, et al. Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. Chin J Traumatol. 2013;16(2):67-76.
[25] LEE QJ, CHANG WYE, WONG YC. Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplasty. 2017; 32(1):139-142.
[26] VEIEN M, SØRENSEN JV, MADSEN F, et al. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand. 2002;46(10): 1206-1211.
[27] HIIPPALA S, STRID L, WENNERSTRAND M, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth.1995;74(5):534-537.
[28] CAMARASA MA, OLLÉ G, SERRA-PRAT M, et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth. 2006; 96(5):576-582.
[29] BENONI G, FREDIN H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br.1996;78(3):434-440.
[30] SEOL YJ, SEON JK, LEE SH, et al. Effect of tranexamic acid on blood loss and blood transfusion reduction after total knee arthroplasty. Knee Surg Relat Res. 2016;28(3):188-193.
|